Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib + mFOLFIRI vs FOLFIRI in 2nd Line Metastatic Pancreatic Cancer
NCT02890355Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2016
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veliparib in pancreatic cancer (PC), sponsored by National Cancer Institute. Started Oct 2016; status: completed.
02
Drugs
veliparib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02890355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02890355.